Stuart Cobb

Stuart Cobb

Chief Scientific OfficeratNeurogene· In proxies 2022–2023

Pay in FY2023+71% from the year before · Neurogene stock +90.4% the same year

Stuart Cobb was paid $784.3K in FY2023 (Dec), up 71%. Neurogene stock rose 90.4% that year.

Pay$100 in the stock at the end of FY21 → $20
Pay is from the Summary Compensation Table of each Neurogene proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeurogenePublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -72%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?